ENDO ONE pitches diode laser lipolysis for face and body contouring

ENDO ONE SRL is promoting its 980-nanometer diode laser platform, ENDO ONE, as a minimally invasive option for precise face and body fat reduction. The company says the system is designed to reduce tissue trauma, improve skin contraction and shorten recovery compared with traditional liposuction and non-invasive alternatives.

Why it matters: - Aesthetic practices are weighing technologies that reduce localized fat without the bleeding, bruising and longer recovery tied to traditional liposuction. - ENDO ONE positions laser-assisted lipolysis as a middle ground between surgery and non-invasive surface treatments, especially when skin tightening and contour precision matter. - The approach may be most relevant for facial zones and smaller body areas where fine shaping is the priority.

What happened: - ENDO ONE SRL outlined its ENDO ONE diode endolaser platform as a minimally invasive option for face and body contouring. - The system uses a 980-nanometer diode laser and bare-tip optical micro-fibers placed directly into targeted adipose tissue. - The company says the platform is manufactured in Italy and is built for high-precision contouring. - ENDO ONE says the technology is designed to liquefy fat, coagulate microvessels and contract soft tissue at the same time.

The details: - Traditional suction liposuction uses blunt cannulas and vacuum suction to mechanically remove fat. - That approach can work well for large-volume debulking above 1 liter, but it also can cause bleeding, hematomas, bruising and skin laxity. - Non-invasive options such as cryolipolysis, high-intensity focused ultrasound and surface radiofrequency act through the skin barrier. - Those methods are described as offering modest fat reduction, often about 20% to 25% in the treated area after several months. - ENDO ONE says laser-assisted lipolysis targets adipose tissue more precisely and can be used for small-to-moderate volumes of about 20 to 500 milliliters. - The 980-nanometer wavelength is said to heat fat and blood, producing fat liquefaction and vascular photocoagulation. - ENDO ONE says the laser raises local tissue temperatures to about 50 to 65 degrees Celsius. - The company says that process disrupts adipocyte membranes, turning fat into a low-viscosity emulsion while preserving fibroseptal structures and major nerves. - ENDO ONE says the laser can coagulate capillaries up to 1 millimeter in diameter, reducing bleeding and postoperative ecchymosis. - The release cites a retrospective analysis of 534 procedures by Reynaud and colleagues in Aesthetic Plastic Surgery as showing less bruising, edema and discomfort than mechanical liposuction. - ENDO ONE says suction liposuction often requires 2 to 4 weeks of recovery and compression. - ENDO ONE says its endolaser procedures typically require 48 to 72 hours of social recovery under local tumescent anesthesia. - The company says laser-assisted lipolysis can be done in outpatient procedure rooms instead of hospital operating suites. - ENDO ONE says clinicians may leave emulsified fat for metabolic clearance in delicate facial areas, including the pre-jowl sulcus and submental fat pad, when the volume is below 20 to 30 milliliters. - For larger areas such as the lower abdomen, flanks or inner thighs, ENDO ONE says clinicians may use gentle low-pressure micro-aspiration after laser emission when emulsified fat exceeds 50 to 100 milliliters. - The release says clinicians use 400-micrometer fibers for facial sculpting, 600-micrometer fibers for the submentum and neck, and 800- to 1,000-micrometer fibers for denser abdominal, flank and thigh fat. - ENDO ONE says the platform can also be used for secondary revision procedures in areas with contour irregularities after prior liposuction. - The company says the treatment is performed under local tumescent anesthesia, with patients remaining awake and discharged the same day.

Between the lines: - The pitch is as much about workflow as results. ENDO ONE is trying to sell a device that fits outpatient aesthetic practices and avoids hospital-based surgery. - The strongest use case appears to be refinement, not major volume removal. That aligns with facial contouring, small body zones and post-liposuction touch-ups. - The emphasis on skin contraction suggests the company is targeting a common limitation of fat-removal procedures: removing volume without leaving loose skin behind.

What's next: - ENDO ONE is directing surgeons and aesthetic practitioners to request consultations for device overviews, consumable fiber logistics and practice integration support. - The company says full technical specifications and evaluation sessions are available through its official consultation portal at the company's announcement. - Adoption will likely depend on how practices compare contour precision, downtime and recovery against existing surgical and non-invasive alternatives.

The bottom line: - ENDO ONE is pitching 980-nanometer laser lipolysis as a precise, outpatient alternative for clinicians who want fat reduction plus tissue tightening without the trauma of traditional liposuction.